Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of sacubitril/valsartan versus ramipril after acute myocardial infarction
MOH_2017-01-03_000007Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) and heart failure (HF) comparing LCZ696 with ramipril (2 arms). Primary endpoint: Objective endpoint component. Started Dec 2016; status: completed.
02
Drugs
sacubitril + valsartanramipril
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on MOH_2017-01-03_000007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-01-03_000007.